Scedosporium Infection in a Tertiary Care Cancer Center: A Review of 25 Cases from 1989-2006
Author(s) -
Gregory A. Lamaris,
Georgios Chamilos,
Russell E. Lewis,
A. Safdar,
Issam Raad,
D. P. Kontoyiannis
Publication year - 2006
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/509579
Subject(s) - scedosporium apiospermum , medicine , incidence (geometry) , tertiary care , cancer , surgery , voriconazole , dermatology , antifungal , physics , optics
We reviewed the records of patients with cancer who had Scedosporium infection (due to Scedosporium apiospermum and Scedosporium prolificans in 21 and 4 patients, respectively). The incidence of Scedosporium infection increased from 0.82 cases per 100,000 patient-inpatient days (in 1993-1998) to 1.33 cases per 100,000 patient-inpatient days (in 1999-2005). Cases of S. prolificans infection occurred only after 2000. Dissemination occurred in 16 patients (64%). The 12-week mortality rates were 70% and 100% for S. apiospermum and S. prolificans infection, respectively.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom